Proton Pump Inhibitors (PPI) are consumed by millions of people around the world, either by prescription or self-medication, some medications of this group are Over-the-counter (OTC) medicines. PPIs have been associated with hypergastrinemia, rebound acid hypersecretion, malabsorption, osteoporosis and infections. This is an updated review of clinical pharmacology aspects of IPBS, with emphasis on safety aspects.
|Original language||American English|
|Number of pages||7|
|Journal||Revista de gastroenterología del Perú : órgano oficial de la Sociedad de Gastroenterología del Perú|
|State||Published - 1 Jan 2011|